A Randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease

Patrizio Pasqualetti; Cristina Bonomini; Gloria Dal Forno; Luca Paulon; Elena Sinforiani; Camillo Marra; Orazio Zanetti; Paolo Maria Rossini

doi:10.1007/BF03325217

A Randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease

Patrizio Pasqualetti
, Cristina Bonomini
, Gloria Dal Forno
, Luca Paulon
, Elena Sinforiani
, Camillo Marra
, Orazio Zanetti^*
, Paolo Maria Rossini

^*Autore corrispondente per questo lavoro

IRCCS Centro San Giovanni di Dio Fatebenefratelli - Brescia
IRCCS San Raffaele Pisana - Roma
Medical College of Wisconsin
IRCCS Fondazione Istituto Neurologico Casimiro Mondino - Pavia
Universita Campus Bio-Medico di Roma

Risultato della ricerca: Contributo in rivista › Articolo › peer review

115 Citazioni (Scopus)

Abstract

Epidemiological studies have examined the association between the use of non-steroidal anti-inflammatory drugs (NSAIDs) and the risk of Alzheimer's disease (AD). Recently, a variety of experimental studies indicates that a subset of NSAIDs, such as ibuprofen or flurbiprofen, also have Abeta-lowering properties in both AD transgenic mice and cell cultures of peripheral, glial and neuronal origin. In this trial, we evaluated whether the non-selective NSAID ibuprofen slows disease progression in patients with mild to moderate AD.

Lingua originale	Inglese
pagine (da-a)	102-110
Numero di pagine	8
Rivista	Aging Clinical and Experimental Research
Volume	21
Numero di pubblicazione	2
DOI	https://doi.org/10.1007/BF03325217
Stato di pubblicazione	Pubblicato - 2009

All Science Journal Classification (ASJC) codes

Invecchiamento
Geriatria e Gerontologia

Keywords

APOE e4
Alzheimer Disease

Accesso al documento

10.1007/BF03325217

Altri file e collegamenti

Cita questo

@article{621b0afedb384c488efb6f684781a296,

title = "A Randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease",

abstract = "Epidemiological studies have examined the association between the use of non-steroidal anti-inflammatory drugs (NSAIDs) and the risk of Alzheimer's disease (AD). Recently, a variety of experimental studies indicates that a subset of NSAIDs, such as ibuprofen or flurbiprofen, also have Abeta-lowering properties in both AD transgenic mice and cell cultures of peripheral, glial and neuronal origin. In this trial, we evaluated whether the non-selective NSAID ibuprofen slows disease progression in patients with mild to moderate AD.",

keywords = "APOE e4, Alzheimer Disease, APOE e4, Alzheimer Disease",

author = "Patrizio Pasqualetti and Cristina Bonomini and \{Dal Forno\}, Gloria and Luca Paulon and Elena Sinforiani and Camillo Marra and Orazio Zanetti and Rossini, \{Paolo Maria\}",

year = "2009",

doi = "10.1007/BF03325217",

language = "English",

volume = "21",

pages = "102--110",

journal = "Aging Clinical and Experimental Research",

issn = "1594-0667",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "2",

}

TY - JOUR

T1 - A Randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease

AU - Pasqualetti, Patrizio

AU - Bonomini, Cristina

AU - Dal Forno, Gloria

AU - Paulon, Luca

AU - Sinforiani, Elena

AU - Marra, Camillo

AU - Zanetti, Orazio

AU - Rossini, Paolo Maria

PY - 2009

Y1 - 2009

N2 - Epidemiological studies have examined the association between the use of non-steroidal anti-inflammatory drugs (NSAIDs) and the risk of Alzheimer's disease (AD). Recently, a variety of experimental studies indicates that a subset of NSAIDs, such as ibuprofen or flurbiprofen, also have Abeta-lowering properties in both AD transgenic mice and cell cultures of peripheral, glial and neuronal origin. In this trial, we evaluated whether the non-selective NSAID ibuprofen slows disease progression in patients with mild to moderate AD.

AB - Epidemiological studies have examined the association between the use of non-steroidal anti-inflammatory drugs (NSAIDs) and the risk of Alzheimer's disease (AD). Recently, a variety of experimental studies indicates that a subset of NSAIDs, such as ibuprofen or flurbiprofen, also have Abeta-lowering properties in both AD transgenic mice and cell cultures of peripheral, glial and neuronal origin. In this trial, we evaluated whether the non-selective NSAID ibuprofen slows disease progression in patients with mild to moderate AD.

KW - APOE e4

KW - Alzheimer Disease

KW - APOE e4

KW - Alzheimer Disease

UR - https://publicatt.unicatt.it/handle/10807/37929

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=66849143701&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=66849143701&origin=inward

U2 - 10.1007/BF03325217

DO - 10.1007/BF03325217

M3 - Article

SN - 1594-0667

VL - 21

SP - 102

EP - 110

JO - Aging Clinical and Experimental Research

JF - Aging Clinical and Experimental Research

IS - 2

ER -

A Randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo